It is well established that estrogen mediates many of its physiological actions by binding to estrogen receptors in the nucleus, which then activate the transcription of target genes. However, as [Hewitt, Deroo and Korach][1] discuss in their Perspective, new work reveals that some of estrogen's effects may be mediated by a nonclassical pathway in which estrogen binds to non-estrogen receptor membrane proteins such as GPR30 ([ Revankar et al .][2]). [1]: http://www.sciencemag.org/cgi/content/full/307/5715/1572 [2]: http://www.sciencemag.org/cgi/content/short/307/5715/1625
No takes yet. Share an insight, caveat, or question.
Hewitt et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: